Skip to main content
. Author manuscript; available in PMC: 2013 Jan 23.
Published in final edited form as: Neurobiol Dis. 2011 Jul 18;44(3):277–283. doi: 10.1016/j.nbd.2011.07.004

Fig. 2.

Fig. 2

Neurological deficit score on a 0–4 scale at 1 day after MCAO in groups with no treatment (control, n=30), tPA treatment (n=29), and tPA+E2 treatment (n=29). *P<0.01.